ROGLIN M TABLET 2 MG/500 MG
Prescription Required
Introduction of Roglin M Tablet
ROGLIN M TABLET 2 MG/500 MG is a combination medicine that helps control blood sugar levels. This medicine is used together with diet and exercise to improve blood sugar control in adults with type 2 diabetes mellitus. It helps in proper utilisation of insulin, thereby lowering the blood sugar level.
ROGLIN M TABLET 2 MG/500 MG should be taken in the dose and duration as advised by your doctor. It must be taken with food to avoid stomach upset. If you miss a dose, take it as soon as possible. However, if it is almost time for your next dose, skip the missed dose and go back to your regular schedule. Do not double the dose. Overdose may lead to low blood sugar (hypoglycemia).
Some people may develop common side effects like nausea, loss of appetite, taste changes, stomach pain, diarrhea, edema (swelling), weight gain, bone fracture, blurred vision, and respiratory tract infection. However, these are temporary and usually subside on their own. If these do not resolve or bother you, please consult your doctor.
Before taking this medicine, inform your doctor if you have any kidney, liver or heart problems. Pregnant or breastfeeding women should also consult their doctor before taking it. Your doctor will check your kidney function tests before starting treatment with it. Avoid excessive alcohol intake while taking it as this may increase the risk of developing some side effects.
Uses of Roglin M Tablet
Benefits of Roglin M Tablet
In Treatment of Type 2 diabetes mellitus
ROGLIN M TABLET 2 MG/500 MG is a combination of two medicines that work together in different ways to lower your blood glucose levels. Lowering blood glucose levels is an essential part of managing diabetes. If you can control your blood glucose level, your risk of getting any of the serious complications of diabetes such as kidney damage, eye damage, nerve problems and loss of limbs is also lowered. Additionally, proper control of diabetes can also reduce the risk of heart disease and stroke. Taking this medicine regularly along with proper diet and exercise will help you live a normal, healthy life. You should keep using this medicine for as long as it is prescribed because it is protecting your future health.
Side effects of Roglin M Tablet
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Roglin M
- Nausea
- Loss of appetite
- Taste change
- Stomach pain
- Diarrhea
- Edema (swelling)
- Weight gain
- Bone fracture
- Blurred vision
- Respiratory tract infection
How to use Roglin M Tablet
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. ROGLIN M TABLET 2 MG/500 MG is to be taken with food.
Safety advice
Alcohol
UNSAFE
It is unsafe to consume alcohol with ROGLIN M TABLET 2 MG/500 MG.
Pregnancy
CONSULT YOUR DOCTOR
ROGLIN M TABLET 2 MG/500 MG may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of ROGLIN M TABLET 2 MG/500 MG during breastfeeding is not available. Please consult your doctor.
Driving
CAUTION
Your ability to drive may be affected if your blood sugar is too low or too high. Do not drive if these symptoms occur.
Kidney
CAUTION
ROGLIN M TABLET 2 MG/500 MG should be used with caution in patients with kidney disease. Dose adjustment of ROGLIN M TABLET 2 MG/500 MG may be needed. Please consult your doctor.
Use of ROGLIN M TABLET 2 MG/500 MG is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Use of ROGLIN M TABLET 2 MG/500 MG is, however, not recommended in patients with severe kidney disease. Regular monitoring of kidney function test is advisable while you are taking this medicine.
Liver
CAUTION
ROGLIN M TABLET 2 MG/500 MG should be used with caution in patients with liver disease. Dose adjustment of ROGLIN M TABLET 2 MG/500 MG may be needed. Please consult your doctor.
ROGLIN M TABLET 2 MG/500 MG is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
ROGLIN M TABLET 2 MG/500 MG is generally started with low dose in patients with mild to moderate liver disease and its use is not recommended in patients with severe liver disease.
All substitutes
For informational purposes only. Consult a doctor before taking any medicines.
ROGLIN M TABLET 2 MG/500 MG
₹3.27/Tablet
Rosimet 2mg/500mg Tablet
Panacea Biotec Pharma Ltd
₹5.22/tablet
60% costlier
Mintide G2 2 mg/500 mg Tablet
Venus Remedies Ltd
₹4.17/tablet
28% costlier
Rositus M Tablet
Aretaeus Pharmaceuticals
₹4.2/tablet
28% costlier
Rosinorm M 2 mg/500 mg Tablet
Micro Labs Ltd
₹4.85/tablet
48% costlier
Rosicon MF 2mg/500mg Tablet
Glenmark Pharmaceuticals Ltd
₹5.62/tablet
72% costlier
Quick tips
Roglin M Tablet
- Monitor your blood sugar level regularly while you are taking this medicine.
- It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol or if you delay or miss a meal.
- Always carry some sugary food or fruit juice with you in case you experience hypoglycemic symptoms such as cold sweats, cool pale skin, tremor, and anxiety.
- Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
- Inform your doctor if you notice weight gain, shortness of breath, irregular heartbeat, or any abnormal swelling.
Fact Box
Habit Forming
No
Therapeutic Class
ANTI DIABETIC
Patient concerns
Patient concerns
Want to share the information?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- Rosiglitazone maleate and metformin hydrochloride. Research Triangle Park, North Carolina: GlaxoSmithKline; 2002 [revised Dec. 2008]. [Accessed 08 Apr. 2019] (online) Available from:
- Drugs.com. Metformin and rosiglitazone. [Accessed 08 Apr. 2019] (online) Available from:
- European Medicine Agency. Rosiglitazone and metformin hydrochloride; 2010. [Accessed 08 Apr. 2019] (online) Available from:
Marketer details
Name: Aristo Pharmaceuticals Pvt Ltd
Address: Mercantile Chamber, 3rd Floor, 12, J.N. Heredia Marg, Ballard Estate, Mumbai – 400 001, India.
Country of origin: India
Lab tests offered by us
Related/Popular tests
BANNED FOR SALE
As per Ministry of Health and Family Welfare